Teva Pharmaceuticals USA, Inc

Teva Pharmaceuticals USA, Inc: 8 recalls listed since February 2026 across FDA.

By year

Metoclopramide Tablets, USP, 5 mg may contain foreign tablets or capsules.

Moderate riskFDAOct 13, 2026Foreign object

TraZODone Hydrochloride Tablets contain foreign tablets or capsules.

Moderate riskFDASep 2, 2026Foreign object

Octreotide Acetate for Injectable Suspension lacks assurance of sterility due to quality system deficiencies.

Moderate riskFDAMay 5, 2026Sterility problem

Claravis (isotretinoin capsule, USP), 10 mg, failed impurities/degradation specifications for specific impurity Tretinoin.

Moderate riskFDAApr 17, 2026Drug impurity

Clonidine Transdermal System was made with an unapproved raw material.

Moderate riskFDAApr 13, 2026Manufacturing problem

Isotretinoin capsules are superpotent and subpotent.

Moderate riskFDAApr 8, 2026Wrong drug strength

Octreotide Acetate for Injectable Suspension lacks assurance of sterility due to quality system deficiencies.

Moderate riskFDAMar 24, 2026Sterility problem

Metoprolol Succinate Extended-Release Tablets failed dissolution specifications.

Moderate riskFDAFeb 27, 2026Drug dissolving problem